Cargando…
Current knowledges in pharmaconutrition: “Ketogenics” in pediatric gliomas
Brain tumors account for 20–25% of pediatric cancers. The most frequent type of brain tumor is Glioma from grade I to grade IV according to the rate of malignancy. Current treatments for gliomas use chemotherapy, radiotherapy, tyrosine kinase inhibitors, monoclonal antibodies and surgery, but each o...
Autores principales: | Cecchi, Nicola, Romanelli, Roberta, Ricevuti, Flavia, Amitrano, Marianna, Carbone, Maria Grazia, Dinardo, Michele, Burgio, Ernesto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10442509/ https://www.ncbi.nlm.nih.gov/pubmed/37614745 http://dx.doi.org/10.3389/fnut.2023.1222908 |
Ejemplares similares
-
Pediatric obesity: prevention is better than care
por: Romanelli, Roberta, et al.
Publicado: (2020) -
Pharmaconutrition revisited for critically ill patients with coronavirus disease 2019 (COVID-19): Does selenium have a place?
por: Manzanares, William, et al.
Publicado: (2021) -
Mitochondrial therapy for Parkinson’s disease: Neuroprotective pharmaconutrition may be disease-modifying
por: Kones, Richard
Publicado: (2010) -
The Ketogenic Effect of Medium-Chain Triacylglycerides
por: Lin, Ting-Yu, et al.
Publicado: (2021) -
Neuroprotection by the Ketogenic Diet: Evidence and Controversies
por: Gough, Sarah M., et al.
Publicado: (2021)